Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional Results available

DiamondTemp™ Ablation System for the Treatment of Paroxysmal Atrial Fibrillation

ClinicalTrials.gov ID: NCT03334630

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT03334630. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 18, 2026, 8:42 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Controlled Clinical Evaluation of the DiamondTemp™ Ablation System for the Treatment of Paroxysmal Atrial Fibrillation

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of the DIAMOND-AF study is to establish the safety and effectiveness of the DiamondTemp System for the treatment of drug refractory, recurrent, symptomatic paroxysmal atrial fibrillation in patients.

Study identification

NCT ID
NCT03334630
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Enrollment
482 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 6, 2017 (Actual)
Primary completion
Nov 18, 2019 (Actual)
Completion
Dec 3, 2019 (Actual)
Last update posted
Feb 13, 2025

2017 – 2019

United States locations

U.S. sites
14
U.S. states
9
U.S. cities
11
Facility City State ZIP Site status
Grandview Medical Center Birmingham Alabama 35242 —
University Of Alabama Birmingham Alabama 35294 —
Keck School Of Medicine Los Angeles California 90033 —
Sequoia Hospital Redwood City California 94062 —
Florida Hospital Orlando Orlando Florida 32803 —
Ochsner Medical Center New Orleans Louisiana 70121 —
Massachusetts General Hospital Boston Massachusetts 02114 —
Jackson Heart Clinic Jackson Mississippi 39216 —
Icahn School of Medicine at Mount Sinai New York New York 10029 —
Montefiore Medical Center New York New York 10467 —
Trident Medical Center Charleston South Carolina 29406 —
Medical University Of South Carolina Charleston South Carolina 29425 —
Texas Cardiac Arrhythmia Research Foundation Austin Texas 78705 —
Houston Methodist Research Institute Houston Texas 77030 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03334630, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 13, 2025 · Synced Nov 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.